We propose to continue our studies of the physical interaction between the erythropoietin receptor (EPO-R) and the Friend Spleen Focus-Forming Virus envelope protein, gp55 (D'Andrea, 1989a; Li, 1990). The interaction of these two polypeptides results in the constitutive activation of the EPO-R and represents a novel mechanism of retroviral leukemogenesis. Our work is health related since other retroviruses may induce hematopoietic malignancies by analogous mechanisms. Also, the activation of the EPO-R by EPO itself has become a standard treatment for various disease related or treatment induced anemias. During Project I of the proposed 5 year study period we will delineate the domains of the EPO-R which are important in signal transduction and in interaction with the gp55. Using a functional assay, the ability of the wild-type EPO-R cDNA to confer EPO dependence on an IL-3 dependent cell, we will screen mutants of the EPO-R for their ability to confer EPO dependence. Using a coimmunoprecipitation assay, we will delineate the EPO-R domain required for binding to the gp55. Chimeric receptors, containing regions of the EPO-R and regions of either the IL-2R beta chain or the IL-3R alpha chain, will further define these two functional domains. Also, using these chimeric receptor mutants we will study the homodimerization of the EPO-R and the amino acid residues which mediate this process. Project II will focus on the functional interaction of gp55 and EPO-R. We will study the normal and abnormal biosynthesis, carbohydrate processing, and ligand-induced phosphorylation of the EPO-R and the effects of gp55 binding. Other subunits of the EPO-R will be identified by crosslinking and coimmunoprecipitation, and various cloning strategies will be used to isolate the cDNAs encoding these other subunits.
| Rondinelli, Beatrice; Gogola, Ewa; Yücel, Hatice et al. (2017) EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation. Nat Cell Biol 19:1371-1378 |
| Karras, Georgios I; Yi, Song; Sahni, Nidhi et al. (2017) HSP90 Shapes the Consequences of Human Genetic Variation. Cell 168:856-866.e12 |
| Mouw, Kent W; Goldberg, Michael S; Konstantinopoulos, Panagiotis A et al. (2017) DNA Damage and Repair Biomarkers of Immunotherapy Response. Cancer Discov 7:675-693 |
| Li, Heng; Lim, Kah Suan; Kim, Hyungjin et al. (2016) Allosteric Activation of Ubiquitin-Specific Proteases by ?-Propeller Proteins UAF1 and WDR20. Mol Cell 63:249-260 |
| Zhang, Haojian; Kozono, David E; O'Connor, Kevin W et al. (2016) TGF-? Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia. Cell Stem Cell 18:668-81 |
| Kais, Zeina; Rondinelli, Beatrice; Holmes, Amie et al. (2016) FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair. Cell Rep 15:2488-99 |
| Bluteau, Dominique; Masliah-Planchon, Julien; Clairmont, Connor et al. (2016) Biallelic inactivation of REV7 is associated with Fanconi anemia. J Clin Invest 126:3580-4 |
| Xie, Jenny; Kim, Hyungjin; Moreau, Lisa A et al. (2015) RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest 125:1523-32 |
| Kim, Hyungjin; Dejsuphong, Donniphat; Adelmant, Guillaume et al. (2014) Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis. Mol Cell 54:107-118 |
| Wojtaszek, Jessica L; Wang, Su; Kim, Hyungjin et al. (2014) Ubiquitin recognition by FAAP20 expands the complex interface beyond the canonical UBZ domain. Nucleic Acids Res 42:13997-4005 |
Showing the most recent 10 out of 99 publications
